Invention Grant
- Patent Title: Combination therapy for treating cancer
-
Application No.: US16985404Application Date: 2020-08-05
-
Publication No.: US11370781B2Publication Date: 2022-06-28
- Inventor: Heike Keilhack , Sarah Kathleen Knutson , Kevin Wayne Kuntz
- Applicant: Epizyme, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Epizyme, Inc.
- Current Assignee: Epizyme, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Cooley LLP
- Agent Heidi A. Erlacher; Christine Dunne
- Main IPC: A61K31/5355
- IPC: A61K31/5355 ; C07D213/64 ; A61K31/4412 ; C07D413/14 ; A61P35/00 ; C07D405/12 ; A61K45/06 ; A61K31/436 ; A61K31/53 ; A61K31/573 ; A61K31/704 ; A61K31/7068 ; A61K31/5377 ; A61K31/4439 ; A61K31/444 ; A61K33/243 ; A61K31/4745 ; A61K31/675
Abstract:
The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer agents such as prednisone, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
Public/Granted literature
- US20210053948A1 COMBINATION THERAPY FOR TREATING CANCER Public/Granted day:2021-02-25
Information query
